_edited.png)
Consumers Expect Lower Cannabis Prices After Federal Rescheduling
Fast Facts
Who / Where: Cannabis consumers in state-legal markets surveyed by NuggMD
What changed: Federal rescheduling of cannabis is expected to eliminate IRS section 280E tax penalties for compliant operators
Effective / Key date: October 8-15, 2025 (survey period); U.S. Treasury and IRS guidance forthcoming
Status: Survey results published following the Trump administration’s federal rescheduling move
DMV impact: Potential retail price shifts across Maryland and surrounding regulated markets as operators gain federal tax relief
The bottom line: Seventy-four percent of surveyed state-legal cannabis consumers expect marijuana businesses to lower product prices following federal rescheduling under the Trump administration, which eliminates the historic 280E tax penalty and allows compliant operators to finally deduct standard business expenses.
As federal policy shifts regarding the classification of cannabis, consumer expectations are shifting right along with it. A recent survey conducted by the cannabis telehealth platform NuggMD captures a widespread belief among buyers across state-legal markets: when operating costs drop due to federal tax relief, retail prices should follow suit.
According to reporting from Marijuana Moment, approximately 74 percent of surveyed cannabis consumers expect licensed operators to pass their newfound savings down to the end buyer. Only 26 percent of respondents believe that cannabis brands and storefronts will absorb the financial benefit without adjusting sticker prices downward.
Why Do Cannabis Businesses Face Such High Taxes?
For decades, the primary financial hurdle for state-licensed cannabis operators has been an Internal Revenue Service rule known as Section 280E. Under this specific tax code, businesses that handle substances classified under Schedule I or II of the federal Controlled Substances Act are barred from taking standard business deductions and credits that are readily available to every other traditional industry.
Because cannabis remained federally restricted alongside heroin and LSD, compliant dispensaries, cultivators, and manufacturers faced extraordinarily high effective tax rates. They could not write off everyday operational expenses like rent, utilities, payroll, or marketing. These heavy financial penalties squeezed profit margins, forcing operators to keep retail prices elevated just to stay afloat in competitive state markets.
However, the Trump administration’s decision to move cannabis down to Schedule III changes the equation entirely. Under Schedule III, section 280E no longer applies to compliant operators. This means licensed businesses will finally be able to deduct ordinary and necessary business expenses from their federal taxes for the first time in modern legal cannabis history.
Do Cannabis Consumers Actually Expect Relief at the Register?
The NuggMD survey interviewed 654 cannabis consumers living in state-legal jurisdictions between October 8 and 15, yielding a margin of error of plus or minus 3.83 percentage points. The data points to a strong public sentiment that the windfall from federal tax restructuring should benefit the everyday buyer rather than just corporate profit margins.
Tyler Elson, director of content at NuggMD, explained to Marijuana Moment that economic pressures are driving these expectations. Rising living costs, elevated interest rates, and a challenging job market have left many shoppers looking for financial relief wherever they can find it. Because cannabis banking regulations and 280E tax penalties have received substantial media attention, many regular consumers understand the sheer magnitude of the savings operators stand to gain.
When Will the IRS Issue Official Tax Guidance?
While the administrative shift toward Schedule III has been initiated, the practical mechanics of the transition are still working their way through federal agencies. In April, the U.S. Department of the Treasury and the IRS indicated that they plan to release official guidance addressing tax issues for marijuana businesses stemming from the rescheduling order.
The Treasury and IRS acknowledged at the time that the Department of Justice’s action would bring significant positive tax consequences for the medical and adult-use cannabis industries. They confirmed that rescheduling removes Section 280E as a barrier to claiming deductions and credits for businesses that no longer traffic in Schedule I or II substances. Despite these announcements, federal agencies have not yet specified an exact date for when the formal guidance will be published.
Legislative pressure has begun to mount around the timeline. In May, a coalition of congressional Democrats sent a formal letter to Treasury Secretary Scott Bessent and IRS Chief Executive Officer Frank Bisignano, urging them to issue prompt instructions. Conversely, a pair of Republican lawmakers expressed concern in June via a separate letter to the Treasury Secretary, questioning the eligibility of cannabis businesses for upcoming federal tax relief.
How Does This Compare to Other States?
State-legal cannabis markets across the country have evolved under vastly different tax structures, creating a fragmented landscape for operators and consumers alike. Traditional state markets like California and Colorado have grappled with high state excise taxes compounding the federal 280E burden, leading to a thriving illicit market that undercuts legal dispensaries on price.
Regulatory Aspect | Previous Federal Status | New Rescheduled Status | Effective Status |
|---|---|---|---|
Substance Scheduling | Schedule I / II | Schedule III | Initiated by administration |
IRS Section 280E | Strictly applied (no deductions) | Removed as a bar to deductions | Pending Treasury/IRS guidance |
Business Expenses | Non-deductible for tax purposes | Eligible for standard write-offs | Pending final agency rules |
Consumer Expectations | High prices driven by heavy tax load | 74% expect retail price reductions | Active public sentiment |
What This Means for DC, Maryland and Virginia Residents
For cannabis consumers in Washington DC, Maryland, and Virginia, federal rescheduling and the potential elimination of 280E could eventually ripple down to local retail markets. Maryland features a robust, state-regulated medical and adult-use program where dispensaries face the same federal tax burdens as operators nationwide. If Maryland cannabis businesses realize substantial tax savings, competitive pressures could encourage dispensaries to adjust prices or offer more aggressive promotions on popular product categories like pre-rolls, concentrates, and edible dosing options.
Meanwhile, consumers navigating Washington DC’s unique grey market and Virginia’s developing regulatory framework will watch closely to see how licensed supply chains adapt. While Virginia works toward establishing a fully operational retail market, and DC maintains its localized delivery and initiative-based sharing culture, federal tax reform sets a broader macroeconomic baseline for the entire mid-Atlantic region. Whether you are ordering through compliant delivery channels or visiting a licensed brick-and-mortar dispensary, operating overhead directly influences what you pay at the register.
What is IRS Section 280E and why did it affect cannabis businesses?
IRS Section 280E is a federal tax code provision that prohibits businesses trafficking in Schedule I or II controlled substances from claiming ordinary business deductions and credits. This forced cannabis operators to pay taxes on their gross income rather than net income, driving up operating costs.
Does federal rescheduling mean cannabis businesses stop paying taxes?
Rescheduled cannabis businesses do not stop paying taxes; rather, moving cannabis to Schedule III removes Section 280E restrictions, allowing compliant operators to deduct standard business expenses like rent and payroll just like any other mainstream business.
When will retail cannabis prices actually drop for consumers?
Retail price reductions depend on when the U.S. Treasury Department and the IRS issue official administrative guidance and how individual state-licensed operators choose to allocate their tax savings relative to local market competition.
How do state taxes interact with federal rescheduling?
State cannabis markets enforce their own state-level excise taxes, sales taxes, and local licensing fees independently of federal tax codes, meaning state tax obligations will remain in place regardless of federal 280E relief.
Where can DMV consumers check for updates on local market pricing?
DMV consumers can monitor local dispensary menus, subscribe to regional newsletter updates, and follow trusted community platforms to track how emerging federal policies influence pricing trends across Maryland and surrounding areas.
Bud Lords Take: Our Read on the Market Shift
Our take at Bud Lords is that while consumer optimism is entirely justified in theory, the reality of retail pricing is rarely that simple. Operators who have survived years of suffocating tax penalties, high interest rates, and banking restrictions may initially use these savings to stabilize their balance sheets, pay off debt, or invest in facility upgrades rather than immediately slashing prices across the board. However, as more operators gain tax relief, healthy market competition will naturally force prices down over time. We advise DMV consumers to keep an eye on local specials and product tier adjustments as federal agencies finally finalize their long-awaited tax guidance.
Have a cannabis story, local update, or strain you want our newsroom to cover? Request a story →
Written by Market Maven AI
Bud Lords AI Cannabis News Writer
Business and finance expert voice. Covers dispensary news, MSO developments, market trends, and financial analysis with industry insight.
Expertise: business · finance
This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.
Comments